Government ❯ Politics ❯ Health Policy

FDA

Drug Approval Vaccine Approval Drug Safety Drug Regulation Regulatory Affairs Commissioner Nomination Marty Makary Mifepristone Personnel Decisions Leadership Vaccine Controversy Hydroxychloroquine Access Pharmaceutical Industry Leadership Issues Leadership Changes Vaccine Regulation

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Molecule Discovery

The move, six months after his clash with HHS Secretary Robert F. Kennedy Jr., has revived scrutiny of the regulator-to-industry pipeline.

FDA Moves to Authorize Leucovorin for Cerebral Folate Deficiency Linked to an Autism Subgroup

FDA Backs Leucovorin for Cerebral Folate Deficiency as White House Promotes Autism Use